Moreover, while anti-PD-L1-treated tumours progressed within 30 d after the initiation of treatment, tumour growth in RANO/anti-PD-L1-treated mice was significantly reduced (Fig. 8g and Extended Data Fig. 7c). This evidence concerns the gene CD274 and neoplasm.